When was MindRank founded?

MindRank was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is MindRank located?

MindRank is headquartered in Shanghai, China.

Who is the current CEO of MindRank?

Zhangming Niu of MindRank. They have also founded 1 company.

How many employees does MindRank have?

As of Jul 31, 2026, the latest employee count at MindRank is 21.

Is MindRank a funded company?

MindRank is a funded company, having raised a total of $82M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 21, 2021.

When was the latest funding round of MindRank?

MindRank's latest funding was a $***** Series B round on Jul 08, 2026, with participation from 0 investor.

Where does MindRank rank among its competitors?

MindRank ranks 13th amongst 212 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was MindRank, which secured $52M in Jul, 2026.

Who are the top competitors of MindRank?

MindRank's top competitors include Schrodinger, Recursion Pharmaceuticals and Valo Health. Among them, MindRank secured the most recent funding round in July, 2026.

MindRank - 2026 Company Profile, Team, Funding & Competitors

MindRank is a series B company based in Shanghai (China), founded in 2019 by Zhangming Niu. It operates as a Provider of AI-based drug candidate identification solutions for drug development. MindRank has raised $82M in funding from investors like Green Pine Capital Partners, Cher Ami and Huagai Capital. The company has 212 active competitors, including 71 funded and 13 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Valo Health.

Company Details

Provider of AI-based drug candidate identification solutions for drug development. The platform enables researchers and pharma industries for identification, virtual screening, and prediction of drug molecule properties for the R & D process.

Website: www.mindrank.ai/en
Email ID: *****@mindrank.ai

Key Metrics

Founded Year

2019

Location

Shanghai, China

Stage

Series B

Total Funding

$82M in 4 rounds

Latest Funding Round

Series B, Jul 08, 2026, $*****

Investors

Green Pine Capital Partners & 3 more

Ranked

13^th among 212 active competitors

Employee Count

21 as on Jul 31, 2026

Similar Companies

OpenEvidence & 2540 more

View MindRank's full profile

MindRank has raised a total funding of $82M over 4 rounds. Its first funding round was on May 21, 2021. MindRank has 4 institutional investors.

Here is the list of recent funding rounds of MindRank:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 08, 2026	9422449	Series B	2620456	3751053	6447671	9156308
Jul 18, 2023	7828952	Series A	7811346	2187653	9675500	1263722
Dec 16, 2021	6733870	Series A	6698765	2517054	Huagai Capital & 1 more	4290442

Access funding benchmarks and valuations. Sign up today!

View details of MindRank's funding rounds and investors

The founders of MindRank is Zhangming Niu. Zhangming Niu is the CEO of MindRank.

Here are the details of MindRank's key team members:

Zhangming Niu: Founder & CEO of MindRank.
Contact Info: 1 email address

View details of MindRank's Founder profiles and Board Members

MindRank's employee count trend

MindRank has 21 employees as of Jul 26. Here is MindRank's employee count trend over the years:

Uncover MindRank's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MindRank include Schrodinger, Recursion Pharmaceuticals and Valo Health. Here is the list of Top 10 competitors of MindRank, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, DCVC & 47 others	72/100
3rd	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	67/100
4th	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	Orbimed, SoftBank Vision Fund & 25 others	67/100
5th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, CapitalG & 6 others	64/100
6th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
7th	In Silico 2014, Cambridge (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Prosperity7 Ventures ... & 36 others	62/100
8th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	62/100
9th	Causaly 2018, London (United Kingdom), Series B	Provider of an AI platform for life sciences and biomedical research	$93M	Index Ventures, EBRD & 14 others	62/100
10th	Aqemia 2019, Paris (France), Series A	Provider of an AI and quantum physics to discover therapeutic molecules	$101M	Cathay Innovation, Elaia & 4 others	62/100
13th	MindRank 2019, Shanghai (China), Series B	Provider of AI-based drug candidate identification solutions for drug development	$82M	Sherpa Healthcare Partners, Huagai Capital ... & 2 others	60/100